Showing results (2021-2030 of 8,257) with videos related to

Sort By:
Pageof 826
Haematologica|September 3, 2026
Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING studyEunice S Wang, Pau Montesinos, Mark D Minden, et al.
Haematologica|September 3, 2026
Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experienceCirino Botta, Andrea Rizzuto, Maria Speciale, et al.
Haematologica|September 3, 2026
Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trialsDouglas Tremblay, Li Chen, Zhuoxin Sun, et al.
Haematologica|September 3, 2026
Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myelomaMarie Christine Wesener, Uta Margareta Demel, Thomas Pabst, et al.
Haematologica|September 3, 2026
Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemiaLulu Wang, Haixia Fu, Yazhen Qin, et al.
Haematologica|September 3, 2026
Single-cell RNA editing identifies aggressive and favorable cellular states in chronic myelomonocytic leukemiaNisansala Wickramasinghe, Doan Bui, Surendra Neupane, et al.
Haematologica|September 17, 2026
Multiparametric flow-cytometry minimal residual disease before hematopoietic stem cell transplantation predicts outcome in pediatric acute myeloid leukemiaBarbara Buldini, Pietro Merli, Elena Varotto, et al.
Haematologica|September 17, 2026
T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?Federico Stella, Joseph A Fraietta, Stephen J Schuster, et al.
Haematologica|September 17, 2026
Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysisAndrew J Cowan, Luuk Gras, Raffaella Cassano, et al.
Haematologica|October 1, 2026
β-thalassemia as a progressive disease: age-related morbidity in the de-LIGHT studyKhaled M Musallam, Angela Vitrano, Alessandro Inzerillo, et al.
Pageof 826